The anticlastogenicity of β-carotene evaluated on human hepatoma cells
- 31 December 1993
- journal article
- Published by Elsevier in Mutation Research Letters
- Vol. 303 (4) , 151-156
- https://doi.org/10.1016/0165-7992(93)90016-o
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Anticlastogenicity in cultured mammalian cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992
- Modulation of cyclophosphamide mutagenicity by vitamin C in the in vivo rodent micronucleus assayTeratogenesis, Carcinogenesis, and Mutagenesis, 1992
- A genetic model for colorectal tumorigenesisCell, 1990
- Co-administration of ascorbic acid with cydophosphamide (CPA) to pregnant mice inhibits the clastogenic activity of CPA in preimplantation murine blastocystsMutagenesis, 1989
- Mechanisms of inhibitors of mutagenesis and carcinogenesis. Classification and overviewMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Influence of dietary carrot on cytostatic drug activity of cyclophosphamide and its main directly acting metabolite: Induction of sister-chromatid exchanges in normal lymphocytes, Chinese hamster ovary cells, and their DNA repair-deficient cell linesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Effect of Dietary β-Carotene on Hepatic Drug-Metabolizing Enzymes in MiceJournal of Clinical Biochemistry and Nutrition, 1987
- β-Carotene: an Unusual Type of Lipid AntioxidantScience, 1984
- Evaluation of a human hepatoma cell line as a target cell in genetic toxicologyMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1983
- Limitations of Metabolic Activation Systems Used with in Vitro Tests for CarcinogensScience, 1980